25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MEDIPOST Co. Ltd
Buy, Hold or Sell?

Let's analyze MEDIPOST Co. Ltd together

I guess you are interested in MEDIPOST Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MEDIPOST Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about MEDIPOST Co. Ltd

I send you an email if I find something interesting about MEDIPOST Co. Ltd.

1. Quick Overview

1.1. Quick analysis of MEDIPOST Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of MEDIPOST Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩9,089.86
Expected worth in 1 year
₩8,663.88
How sure are you?
55.0%

+ What do you gain per year?

Total Gains per Share
₩-425.98
Return On Investment
-3.4%

For what price can you sell your share?

Current Price per Share
₩12,350.00
Expected price per share
₩8,920 - ₩15,885
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of MEDIPOST Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩12,350.00

2.2. Growth of MEDIPOST Co. Ltd (5 min.)




Is MEDIPOST Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$216.9m$121.2m$82.1m40.4%

How much money is MEDIPOST Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$803k$3.1m-$2.3m-297.0%
Net Profit Margin7.3%28.3%--

How much money comes from the company's main activities?

2.3. Financial Health of MEDIPOST Co. Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of MEDIPOST Co. Ltd?

Welcome investor! MEDIPOST Co. Ltd's management wants to use your money to grow the business. In return you get a share of MEDIPOST Co. Ltd.

First you should know what it really means to hold a share of MEDIPOST Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of MEDIPOST Co. Ltd is ₩12,350. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of MEDIPOST Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in MEDIPOST Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩9,089.86. Based on the TTM, the Book Value Change Per Share is ₩-106.49 per quarter. Based on the YOY, the Book Value Change Per Share is ₩195.71 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of MEDIPOST Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.060.0%0.010.0%0.200.0%-0.040.0%-0.010.0%
Usd Book Value Change Per Share0.060.0%-0.070.0%0.140.0%0.030.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.060.0%-0.070.0%0.140.0%0.030.0%0.030.0%
Usd Price Per Share4.57-5.09-10.20-14.80-35.23-
Price to Earnings Ratio19.52-0.79-6.01--462.80--138.09-
Price-to-Total Gains Ratio78.10-10.43-33.34-228.34-428.21-
Price to Book Ratio0.72-0.76-1.47-2.52-6.29-
Price-to-Total Gains Ratio78.10-10.43-33.34-228.34-428.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.645
Number of shares115
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.03
Usd Total Gains Per Share-0.070.03
Gains per Quarter (115 shares)-8.573.27
Gains per Year (115 shares)-34.2913.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-34-440133
20-69-7802616
30-103-11203929
40-137-14605242
50-171-18006555
60-206-21407868
70-240-24809181
80-274-282010594
90-309-3160118107
100-343-3500131120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%8.012.00.040.0%17.016.07.042.5%20.016.010.043.5%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%10.010.00.050.0%22.018.00.055.0%24.022.00.052.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%10.010.00.050.0%22.018.00.055.0%24.022.00.052.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of MEDIPOST Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--83.608-106.495+227%195.711-57%40.570+106%37.333+124%
Book Value Per Share--9089.8579595.366-5%9968.053-9%8866.559+3%8641.641+5%
Current Ratio--2.8092.622+7%1.219+130%2.238+26%2.544+10%
Debt To Asset Ratio--0.3000.329-9%0.555-46%0.441-32%0.356-16%
Debt To Equity Ratio--0.4310.501-14%1.255-66%0.842-49%0.614-30%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--89691227050.00082928260127.500+8%100658391260.982-11%277893344144.507-68%757246288029.626-88%
Eps--83.63420.621+306%287.948-71%-55.315+166%-21.160+125%
Ev To Ebitda Ratio--infnannan%infnan%nannan%nannan%
Ev To Sales Ratio--1.2801.187+8%1.516-16%5.281-76%18.669-93%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.825+21%
Market Cap189940530000.000-17%222665066050.000223784519962.500-1%253986422625.982-12%359392521468.007-38%822748592709.126-73%
Net Profit Margin--0.1630.073+124%0.283-43%-0.073+145%-0.030+118%
Operating Margin----0%-0.0960%-0.1090%-0.0780%
Operating Ratio--0.7861.565-50%1.312-40%0.956-18%0.900-13%
Pb Ratio1.359+47%0.7180.763-6%1.467-51%2.524-72%6.294-89%
Pe Ratio36.917+47%19.5200.790+2370%6.010+225%-462.804+2471%-138.087+807%
Price Per Share12350.000+47%6530.0007275.000-10%14569.999-55%21146.498-69%50331.996-87%
Price To Free Cash Flow Ratio----7.5320%-20.2940%4.359-100%10.911-100%
Price To Total Gains Ratio147.712+47%78.10210.434+649%33.343+134%228.338-66%428.205-82%
Quick Ratio---1.283-100%1.429-100%2.266-100%1.807-100%
Return On Assets--0.0060.002+182%0.012-48%-0.004+169%-0.002+132%
Return On Equity--0.0090.003+232%0.028-67%-0.009+194%-0.004+142%
Total Gains Per Share--83.608-106.495+227%195.711-57%40.570+106%37.333+124%
Usd Book Value--216967159.500203391790.200+7%121264174.281+79%119697811.398+81%106098227.127+104%
Usd Book Value Change Per Share--0.059-0.075+227%0.137-57%0.028+106%0.026+124%
Usd Book Value Per Share--6.3636.717-5%6.978-9%6.207+3%6.049+5%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--62783858.93558049782.089+8%70460873.883-11%194525340.901-68%530072401.621-88%
Usd Eps--0.0590.014+306%0.202-71%-0.039+166%-0.015+125%
Usd Free Cash Flow----3000668.8150%-2900278.5540%-1851856.6140%-981505.3050%
Usd Market Cap132958371.000-17%155865546.235156649163.974-1%177790495.838-12%251574765.028-38%575924014.896-73%
Usd Price Per Share8.645+47%4.5715.093-10%10.199-55%14.803-69%35.232-87%
Usd Profit--1996260.700803064.579+149%3187788.868-37%-489356.079+125%-197392.019+110%
Usd Revenue--12261052.30012251521.506+0%11734821.303+4%10290630.633+19%8669224.921+41%
Usd Total Gains Per Share--0.059-0.075+227%0.137-57%0.028+106%0.026+124%
 EOD+2 -5MRQTTM+22 -7YOY+9 -205Y+21 -910Y+22 -9

3.3 Fundamental Score

Let's check the fundamental score of MEDIPOST Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.917
Price to Book Ratio (EOD)Between0-11.359
Net Profit Margin (MRQ)Greater than00.163
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.809
Debt to Asset Ratio (MRQ)Less than10.300
Debt to Equity Ratio (MRQ)Less than10.431
Return on Equity (MRQ)Greater than0.150.009
Return on Assets (MRQ)Greater than0.050.006
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of MEDIPOST Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.552
Ma 20Greater thanMa 5010,787.000
Ma 50Greater thanMa 1008,578.800
Ma 100Greater thanMa 2007,282.300
OpenGreater thanClose11,870.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About MEDIPOST Co. Ltd

MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. It operates CELLTREE, an umbilical cord blood bank; and offers cord blood banking services to treat various incurable diseases. The company also markets CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell drugs, such as PNEUMOSTEM, which is in completed Phase II clinical trial in South Korea, as well as in Phase I/II clinical trial in the United States for the preventative treatment of bronchopulmonary dysplasia; and NEUROSTEM that is in Phase I/IIa clinical study to treat Alzheimer's disease. Further, the company develops SMUP-IA-01, which has completed phase I clinical trial for the treatment of osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy, as well as offers nutritional and dietary supplements under the MOVITA brand name. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 21:39:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit MEDIPOST Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • A Net Profit Margin of 16.3% means that ₩0.16 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MEDIPOST Co. Ltd:

  • The MRQ is 16.3%. The company is making a huge profit. +2
  • The TTM is 7.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ16.3%TTM7.3%+9.0%
TTM7.3%YOY28.3%-21.1%
TTM7.3%5Y-7.3%+14.6%
5Y-7.3%10Y-3.0%-4.3%
4.3.1.2. Return on Assets

Shows how efficient MEDIPOST Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • 0.6% Return on Assets means that MEDIPOST Co. Ltd generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.2%+0.4%
TTM0.2%YOY1.2%-1.0%
TTM0.2%5Y-0.4%+0.7%
5Y-0.4%10Y-0.2%-0.2%
4.3.1.3. Return on Equity

Shows how efficient MEDIPOST Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • 0.9% Return on Equity means MEDIPOST Co. Ltd generated ₩0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.3%+0.6%
TTM0.3%YOY2.8%-2.5%
TTM0.3%5Y-0.9%+1.1%
5Y-0.9%10Y-0.4%-0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of MEDIPOST Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient MEDIPOST Co. Ltd is operating .

  • Measures how much profit MEDIPOST Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-9.6%+9.6%
TTM-5Y-10.9%+10.9%
5Y-10.9%10Y-7.8%-3.1%
4.3.2.2. Operating Ratio

Measures how efficient MEDIPOST Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are ₩0.79 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.786. The company is efficient in keeping operating costs low. +1
  • The TTM is 1.565. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.786TTM1.565-0.779
TTM1.565YOY1.312+0.253
TTM1.5655Y0.956+0.608
5Y0.95610Y0.900+0.057
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of MEDIPOST Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if MEDIPOST Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A Current Ratio of 2.81 means the company has ₩2.81 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of MEDIPOST Co. Ltd:

  • The MRQ is 2.809. The company is able to pay all its short-term debts. +1
  • The TTM is 2.622. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.809TTM2.622+0.187
TTM2.622YOY1.219+1.403
TTM2.6225Y2.238+0.384
5Y2.23810Y2.544-0.306
4.4.3.2. Quick Ratio

Measures if MEDIPOST Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.283-1.283
TTM1.283YOY1.429-0.146
TTM1.2835Y2.266-0.983
5Y2.26610Y1.807+0.459
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of MEDIPOST Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of MEDIPOST Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare MEDIPOST Co. Ltd to Biotechnology & Medical Research industry mean.
  • A Debt to Asset Ratio of 0.30 means that MEDIPOST Co. Ltd assets are financed with 30.0% credit (debt) and the remaining percentage (100% - 30.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.300. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.329. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.300TTM0.329-0.029
TTM0.329YOY0.555-0.226
TTM0.3295Y0.441-0.112
5Y0.44110Y0.356+0.086
4.5.4.2. Debt to Equity Ratio

Measures if MEDIPOST Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • A Debt to Equity ratio of 43.1% means that company has ₩0.43 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.431. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.501. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.431TTM0.501-0.070
TTM0.501YOY1.255-0.754
TTM0.5015Y0.842-0.341
5Y0.84210Y0.614+0.229
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings MEDIPOST Co. Ltd generates.

  • Above 15 is considered overpriced but always compare MEDIPOST Co. Ltd to the Biotechnology & Medical Research industry mean.
  • A PE ratio of 19.52 means the investor is paying ₩19.52 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MEDIPOST Co. Ltd:

  • The EOD is 36.917. Based on the earnings, the company is overpriced. -1
  • The MRQ is 19.520. Based on the earnings, the company is fair priced.
  • The TTM is 0.790. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD36.917MRQ19.520+17.397
MRQ19.520TTM0.790+18.729
TTM0.790YOY6.010-5.220
TTM0.7905Y-462.804+463.594
5Y-462.80410Y-138.087-324.717
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MEDIPOST Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-7.532+7.532
TTM-7.532YOY-20.294+12.763
TTM-7.5325Y4.359-11.891
5Y4.35910Y10.911-6.552
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of MEDIPOST Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A PB ratio of 0.72 means the investor is paying ₩0.72 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of MEDIPOST Co. Ltd:

  • The EOD is 1.359. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.718. Based on the equity, the company is cheap. +2
  • The TTM is 0.763. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.359MRQ0.718+0.640
MRQ0.718TTM0.763-0.045
TTM0.763YOY1.467-0.704
TTM0.7635Y2.524-1.761
5Y2.52410Y6.294-3.770
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -5,036,240-1,021,971-6,058,210-3,637,758-9,695,9683,733,044-5,962,92416,597,53210,634,608



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets442,926,924
Total Liabilities132,973,839
Total Stockholder Equity308,304,547
 As reported
Total Liabilities 132,973,839
Total Stockholder Equity+ 308,304,547
Total Assets = 442,926,924

Assets

Total Assets442,926,924
Total Current Assets159,470,989
Long-term Assets283,455,935
Total Current Assets
Total Current Assets  (as reported)159,470,989
Total Current Assets  (calculated)0
+/- 159,470,989
Long-term Assets
Long-term Assets  (as reported)283,455,935
Long-term Assets  (calculated)0
+/- 283,455,935

Liabilities & Shareholders' Equity

Total Current Liabilities56,770,755
Long-term Liabilities76,203,083
Total Stockholder Equity308,304,547
Total Current Liabilities
Total Current Liabilities  (as reported)56,770,755
Total Current Liabilities  (calculated)0
+/- 56,770,755
Long-term Liabilities
Long-term Liabilities  (as reported)76,203,083
Long-term Liabilities  (calculated)0
+/- 76,203,083
Total Stockholder Equity
Total Stockholder Equity (as reported)308,304,547
Total Stockholder Equity (calculated)0
+/- 308,304,547
Other
Common Stock Shares Outstanding 34,099
Net Invested Capital 308,304,547
Net Working Capital 102,700,234



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
137,781,506
136,263,011
136,147,480
145,771,193
147,413,605
149,714,349
171,009,809
185,969,420
185,221,698
185,585,151
184,348,702
182,932,725
182,938,160
181,527,344
179,952,356
179,264,591
181,964,553
181,961,225
181,639,972
181,672,509
139,141,379
168,125,466
169,772,714
175,753,120
217,861,054
216,285,060
217,039,236
213,719,039
211,059,847
212,929,140
210,802,240
219,811,429
220,036,908
223,060,811
222,860,058
254,093,739
267,405,322
364,867,566
366,929,630
397,790,903
394,672,004
395,954,463
391,091,968
449,392,586
442,252,362
442,926,924
442,926,924442,252,362449,392,586391,091,968395,954,463394,672,004397,790,903366,929,630364,867,566267,405,322254,093,739222,860,058223,060,811220,036,908219,811,429210,802,240212,929,140211,059,847213,719,039217,039,236216,285,060217,861,054175,753,120169,772,714168,125,466139,141,379181,672,509181,639,972181,961,225181,964,553179,264,591179,952,356181,527,344182,938,160182,932,725184,348,702185,585,151185,221,698185,969,420171,009,809149,714,349147,413,605145,771,193136,147,480136,263,011137,781,506
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,151,792
39,016,475
41,945,192
44,517,711
47,622,899
53,329,095
57,025,630
95,915,655
91,566,354
86,847,986
91,227,140
85,204,796
88,616,046
86,269,280
87,619,756
87,034,869
88,617,795
84,920,389
81,079,602
94,709,193
197,867,683
152,155,672
151,810,655
150,217,814
146,851,826
128,703,910
193,511,416
191,182,408
159,470,989
159,470,989191,182,408193,511,416128,703,910146,851,826150,217,814151,810,655152,155,672197,867,68394,709,19381,079,60284,920,38988,617,79587,034,86987,619,75686,269,28088,616,04685,204,79691,227,14086,847,98691,566,35495,915,65557,025,63053,329,09547,622,89944,517,71141,945,19239,016,47542,151,79200000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,947,584
6,387,433
9,060,325
7,286,267
8,526,106
6,490,134
6,316,891
50,484,199
10,834,248
7,698,331
11,908,557
7,481,931
9,995,643
8,504,204
8,216,045
7,113,303
9,967,598
7,534,065
9,716,637
6,000
0
0
14,854,523
32,844,294
74,280,220
56,949,433
37,523,524
20,611,272
0
020,611,27237,523,52456,949,43374,280,22032,844,29414,854,523006,0009,716,6377,534,0659,967,5987,113,3038,216,0458,504,2049,995,6437,481,93111,908,5577,698,33110,834,24850,484,1996,316,8916,490,1348,526,1067,286,2679,060,3256,387,43312,947,58400000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,767,920
15,666,659
12,573,096
15,987,375
10,967,360
7,078,750
29,977,385
4,070,000
4,070,000
4,070,000
4,319,309
0
0
48,594,073
48,324,043
48,327,052
48,081,673
44,112,814
46,600,161
64,556,018
114,555,360
109,429,554
108,559,270
86,402,795
39,005,170
38,752,366
122,031,140
134,898,789
0
0134,898,789122,031,14038,752,36639,005,17086,402,795108,559,270109,429,554114,555,36064,556,01846,600,16144,112,81448,081,67348,327,05248,324,04348,594,073004,319,3094,070,0004,070,0004,070,00029,977,3857,078,75010,967,36015,987,37512,573,09615,666,65914,767,92000000000000000000
       Net Receivables 
2,433,421
3,199,846
2,429,845
4,821,802
2,853,365
3,833,694
2,605,771
3,532,016
2,095,717
1,985,180
1,476,990
2,409,292
2,569,191
2,794,658
2,568,450
2,298,953
4,072,345
2,809,030
5,010,099
6,972,930
7,728,465
8,038,406
8,001,306
7,118,039
8,013,860
7,016,953
6,289,940
10,200,490
11,194,277
10,937,214
10,395,465
11,911,084
11,702,572
12,007,062
11,403,373
11,453,818
12,145,311
11,395,469
11,816,103
12,417,994
13,496,242
12,820,721
12,062,366
11,509,174
12,487,807
0
012,487,80711,509,17412,062,36612,820,72113,496,24212,417,99411,816,10311,395,46912,145,31111,453,81811,403,37312,007,06211,702,57211,911,08410,395,46510,937,21411,194,27710,200,4906,289,9407,016,9538,013,8607,118,0398,001,3068,038,4067,728,4656,972,9305,010,0992,809,0304,072,3452,298,9532,568,4502,794,6582,569,1912,409,2921,476,9901,985,1802,095,7173,532,0162,605,7713,833,6942,853,3654,821,8022,429,8453,199,8462,433,421
       Inventory 
4,708,154
4,786,881
5,138,330
5,155,455
5,243,182
5,846,059
7,112,063
7,543,704
7,784,381
8,374,658
8,948,588
8,426,303
8,813,693
8,323,905
7,459,069
6,566,655
6,891,421
6,885,361
6,388,144
7,509,734
6,983,602
6,874,528
7,624,446
7,455,260
7,063,120
7,579,412
7,970,538
7,562,835
7,971,999
8,568,261
7,742,137
9,425,067
9,866,949
9,363,290
9,181,530
9,859,448
9,496,192
9,115,649
9,135,731
9,710,929
11,104,481
12,161,178
14,201,314
14,516,898
14,490,882
0
014,490,88214,516,89814,201,31412,161,17811,104,4819,710,9299,135,7319,115,6499,496,1929,859,4489,181,5309,363,2909,866,9499,425,0677,742,1378,568,2617,971,9997,562,8357,970,5387,579,4127,063,1207,455,2607,624,4466,874,5286,983,6027,509,7346,388,1446,885,3616,891,4216,566,6557,459,0698,323,9058,813,6938,426,3038,948,5888,374,6587,784,3817,543,7047,112,0635,846,0595,243,1825,155,4555,138,3304,786,8814,708,154
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
245,980,248
244,454,189
249,102,637
262,388,059
255,881,170
251,069,954
283,455,935
283,455,935251,069,954255,881,170262,388,059249,102,637244,454,189245,980,248000000000000000000000000000000000000000
       Property Plant Equipment 
21,744,519
24,648,246
25,850,432
38,625,152
44,808,908
54,053,309
56,498,956
47,561,110
47,121,475
47,191,065
46,710,339
45,881,866
45,418,337
45,100,827
44,664,855
44,246,079
43,749,805
43,241,208
43,065,072
42,587,046
42,229,856
70,645,558
70,023,126
70,092,018
70,980,449
70,703,325
74,046,212
72,331,496
76,698,093
76,462,979
77,043,032
85,021,231
86,579,800
89,115,685
93,690,449
110,948,610
111,397,897
111,321,025
110,924,917
137,670,263
138,532,447
136,802,046
136,035,323
139,366,579
139,105,452
0
0139,105,452139,366,579136,035,323136,802,046138,532,447137,670,263110,924,917111,321,025111,397,897110,948,61093,690,44989,115,68586,579,80085,021,23177,043,03276,462,97976,698,09372,331,49674,046,21270,703,32570,980,44970,092,01870,023,12670,645,55842,229,85642,587,04643,065,07243,241,20843,749,80544,246,07944,664,85545,100,82745,418,33745,881,86646,710,33947,191,06547,121,47547,561,11056,498,95654,053,30944,808,90838,625,15225,850,43224,648,24621,744,519
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,857,238
3,932,232
1,554,786
1,554,786
1,554,786
1,554,786
1,554,786
1,554,786
1,554,786
1,554,786
0
01,554,7861,554,7861,554,7861,554,7861,554,7861,554,7861,554,7861,554,7863,932,2323,857,23800000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,553,788
13,331,718
13,757,374
12,814,733
11,229,766
8,706,839
10,140,388
13,462,134
14,051,592
13,373,118
13,816,407
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000013,816,40713,373,11814,051,59213,462,13410,140,3888,706,83911,229,76612,814,73313,757,37413,331,7189,553,78800000000000000000
       Intangible Assets 
795,710
786,526
1,088,157
726,907
922,344
1,101,885
1,052,624
1,087,957
1,213,511
47,589,087
48,687,432
1,247,726
46,762,618
47,586,188
48,936,582
1,940,731
51,450,748
51,841,539
52,066,112
1,957,289
1,939,241
1,865,984
1,790,370
1,833,317
2,254,527
2,215,472
6,082,071
6,079,758
5,683,022
5,302,296
4,829,760
4,364,127
3,706,865
3,274,055
2,990,626
2,832,750
2,658,094
2,763,670
2,602,484
2,706,753
2,472,896
3,247,470
3,054,679
2,787,831
2,593,361
0
02,593,3612,787,8313,054,6793,247,4702,472,8962,706,7532,602,4842,763,6702,658,0942,832,7502,990,6263,274,0553,706,8654,364,1274,829,7605,302,2965,683,0226,079,7586,082,0712,215,4722,254,5271,833,3171,790,3701,865,9841,939,2411,957,28952,066,11251,841,53951,450,7481,940,73148,936,58247,586,18846,762,6181,247,72648,687,43247,589,0871,213,5111,087,9571,052,6241,101,885922,344726,9071,088,157786,526795,710
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-35,774,654
-1
1
0
0
001-1-35,774,65400000000000000000000000000000000000000000
> Total Liabilities 
19,201,858
19,429,054
19,708,976
28,348,253
30,281,862
32,880,837
54,586,199
68,631,671
65,535,829
63,668,662
46,978,806
36,450,640
35,217,214
36,376,661
35,575,989
35,955,536
37,660,556
36,597,952
37,607,525
40,206,929
42,226,654
43,629,802
45,686,033
48,949,436
90,588,414
87,978,133
90,088,907
102,130,206
93,920,817
96,950,920
99,521,604
103,267,394
83,551,283
85,644,371
85,369,475
94,614,602
113,993,452
223,871,773
208,445,503
217,820,386
218,579,887
217,563,084
159,565,753
135,735,223
135,150,224
132,973,839
132,973,839135,150,224135,735,223159,565,753217,563,084218,579,887217,820,386208,445,503223,871,773113,993,45294,614,60285,369,47585,644,37183,551,283103,267,39499,521,60496,950,92093,920,817102,130,20690,088,90787,978,13390,588,41448,949,43645,686,03343,629,80242,226,65440,206,92937,607,52536,597,95237,660,55635,955,53635,575,98936,376,66135,217,21436,450,64046,978,80663,668,66265,535,82968,631,67154,586,19932,880,83730,281,86228,348,25319,708,97619,429,05419,201,858
   > Total Current Liabilities 
7,928,594
8,025,454
6,082,001
9,327,167
5,451,257
4,105,987
6,319,036
9,889,867
6,217,708
19,125,140
18,420,279
18,789,098
18,535,100
18,690,012
18,770,002
3,229,437
4,461,683
3,640,439
3,751,819
5,178,603
5,112,410
19,414,154
20,421,198
21,291,750
20,720,239
15,706,978
17,736,801
39,043,845
27,080,696
59,309,454
62,862,968
63,159,527
41,609,542
40,477,536
39,009,909
41,395,264
23,621,594
84,450,296
78,763,747
154,588,012
156,193,357
146,931,975
89,755,071
63,321,097
59,968,619
56,770,755
56,770,75559,968,61963,321,09789,755,071146,931,975156,193,357154,588,01278,763,74784,450,29623,621,59441,395,26439,009,90940,477,53641,609,54263,159,52762,862,96859,309,45427,080,69639,043,84517,736,80115,706,97820,720,23921,291,75020,421,19819,414,1545,112,4105,178,6033,751,8193,640,4394,461,6833,229,43718,770,00218,690,01218,535,10018,789,09818,420,27919,125,1406,217,7089,889,8676,319,0364,105,9875,451,2579,327,1676,082,0018,025,4547,928,594
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
0
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
9,994,920
0
0
0
0
0
0
0000009,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,9209,994,920015,594,92015,594,92015,594,92015,594,92015,594,92015,594,92015,594,92015,594,92000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
15,594,920
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,778,873
50,161,144
46,299,295
3,000,000
3,000,000
3,000,000
0
03,000,0003,000,0003,000,00046,299,29550,161,14447,778,8730000000000000015,594,92015,594,92015,594,92015,594,92015,594,92015,594,92015,594,92015,594,92000000000000000000
       Accounts payable 
1,550,044
1,850,523
1,681,853
4,341,410
1,709,966
1,414,635
1,845,970
4,287,607
2,839,266
817,928
189,797
918,599
636,837
842,134
652,866
886,913
1,301,400
900,373
1,051,607
1,749,437
1,087,999
693,347
1,307,451
785,764
895,961
1,020,659
578,549
1,313,103
884,967
1,067,465
976,932
1,571,089
2,454,329
1,233,467
972,313
1,281,368
934,651
1,804,090
1,548,968
1,478,298
1,838,027
2,010,521
3,756,281
1,514,079
1,373,700
0
01,373,7001,514,0793,756,2812,010,5211,838,0271,478,2981,548,9681,804,090934,6511,281,368972,3131,233,4672,454,3291,571,089976,9321,067,465884,9671,313,103578,5491,020,659895,961785,7641,307,451693,3471,087,9991,749,4371,051,607900,3731,301,400886,913652,866842,134636,837918,599189,797817,9282,839,2664,287,6071,845,9701,414,6351,709,9664,341,4101,681,8531,850,5231,550,044
       Other Current Liabilities 
5,803,204
6,174,931
4,400,148
4,985,757
3,741,291
2,691,352
4,473,066
5,602,257
3,378,442
2,712,292
2,635,562
2,275,579
2,303,343
2,252,958
2,522,216
2,342,524
3,160,283
2,740,066
2,700,212
3,429,166
4,024,411
2,693,849
2,952,506
4,447,784
3,533,400
3,606,551
5,834,864
25,387,108
14,287,990
18,472,591
20,253,602
18,096,034
11,921,203
10,617,351
8,102,550
9,090,354
10,040,542
36,494,210
28,107,081
0
1
1,025,345
1
0
0
0
00011,025,3451028,107,08136,494,21010,040,5429,090,3548,102,55010,617,35111,921,20318,096,03420,253,60218,472,59114,287,99025,387,1085,834,8643,606,5513,533,4004,447,7842,952,5062,693,8494,024,4113,429,1662,700,2122,740,0663,160,2832,342,5242,522,2162,252,9582,303,3432,275,5792,635,5622,712,2923,378,4425,602,2574,473,0662,691,3523,741,2914,985,7574,400,1486,174,9315,803,204
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,625,117
62,386,530
70,631,109
69,810,681
72,414,126
75,181,605
76,203,083
76,203,08375,181,60572,414,12669,810,68170,631,10962,386,53060,625,117000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,047,661
25,328,467
26,285,561
413,763
342,020
270,789
937,816
1,679,347
1,331,510
1,229,215
18,767,374
1,326,269
1,152,679
1,239,700
0
0
0
0
0
0
0000001,239,7001,152,6791,326,26918,767,3741,229,2151,331,5101,679,347937,816270,789342,020413,76326,285,56125,328,46730,047,66100000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-15,594,920
-15,594,920
-15,594,920
-15,594,920
-15,594,920
-15,594,920
-15,594,920
-15,594,920
0
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-9,994,920
-8,255,906
1,936,198
1,757,600
1,571,000
1,648,203
1,561,613
0
01,561,6131,648,2031,571,0001,757,6001,936,198-8,255,906-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,920-9,994,9200-15,594,920-15,594,920-15,594,920-15,594,920-15,594,920-15,594,920-15,594,920-15,594,92000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
-1
0
0
1
0
0100-101000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,215,200
5,885,778
5,556,356
5,226,934
4,897,512
4,568,090
4,238,667
3,909,245
3,579,823
3,250,401
2,920,979
2,591,557
2,262,135
1,932,713
1,603,291
1,273,868
944,446
615,024
558,726
502,428
0
0
0
0
0
0
0
0000000502,428558,726615,024944,4461,273,8681,603,2911,932,7132,262,1352,591,5572,920,9793,250,4013,579,8233,909,2454,238,6674,568,0904,897,5125,226,9345,556,3565,885,7786,215,2000000000000000000000
> Total Stockholder Equity
117,816,283
116,069,729
115,787,290
116,423,818
116,114,379
115,977,914
115,994,486
116,577,414
119,036,724
121,288,328
136,691,286
146,484,431
147,723,455
145,153,458
144,379,234
143,312,540
144,307,248
145,366,804
144,036,248
141,469,236
96,924,025
124,505,628
124,096,635
126,813,844
127,283,154
128,317,829
126,950,329
111,588,832
117,139,030
115,978,220
111,280,636
116,544,034
136,485,625
137,416,440
137,490,583
159,479,137
153,411,870
140,995,793
158,484,127
179,970,517
173,498,213
176,129,974
229,316,939
311,554,526
305,191,672
308,304,547
308,304,547305,191,672311,554,526229,316,939176,129,974173,498,213179,970,517158,484,127140,995,793153,411,870159,479,137137,490,583137,416,440136,485,625116,544,034111,280,636115,978,220117,139,030111,588,832126,950,329128,317,829127,283,154126,813,844124,096,635124,505,62896,924,025141,469,236144,036,248145,366,804144,307,248143,312,540144,379,234145,153,458147,723,455146,484,431136,691,286121,288,328119,036,724116,577,414115,994,486115,977,914116,114,379116,423,818115,787,290116,069,729117,816,283
   Common Stock
3,583,026
3,583,026
3,583,026
3,583,026
3,603,026
3,603,026
3,603,026
3,603,026
3,603,026
3,603,026
3,786,978
3,893,393
3,916,302
3,916,302
3,929,211
3,929,211
3,929,211
3,929,211
3,929,211
3,929,211
3,934,211
3,934,211
3,934,211
3,934,211
3,934,211
7,808,921
7,808,921
7,808,921
7,808,921
7,808,921
7,808,921
7,808,921
8,132,097
8,132,097
8,132,097
8,132,097
8,132,097
8,132,097
8,132,097
8,132,097
0
0
0
0
0
0
0000008,132,0978,132,0978,132,0978,132,0978,132,0978,132,0978,132,0978,132,0977,808,9217,808,9217,808,9217,808,9217,808,9217,808,9217,808,9213,934,2113,934,2113,934,2113,934,2113,934,2113,929,2113,929,2113,929,2113,929,2113,929,2113,929,2113,916,3023,916,3023,893,3933,786,9783,603,0263,603,0263,603,0263,603,0263,603,0263,603,0263,583,0263,583,0263,583,0263,583,026
   Retained Earnings 
14,580,780
13,054,991
685,111
14,559,889
13,201,255
12,618,844
12,189,631
12,545,528
14,790,746
16,832,477
15,926,817
15,565,783
586,701
11,923,675
10,497,383
9,442,186
10,801,356
11,841,113
10,601,473
7,977,357
-38,093,450
-32,718,477
-33,827,869
-32,215,493
-31,821,630
-30,643,056
-31,824,173
-47,260,154
-42,353,821
-43,367,747
-47,646,384
-47,349,171
-53,166,490
-53,013,007
-53,042,235
-47,929,624
-53,707,966
-62,525,025
-45,878,061
-41,896,538
-48,763,785
-44,641,798
-47,924,377
-35,978,217
-42,818,949
0
0-42,818,949-35,978,217-47,924,377-44,641,798-48,763,785-41,896,538-45,878,061-62,525,025-53,707,966-47,929,624-53,042,235-53,013,007-53,166,490-47,349,171-47,646,384-43,367,747-42,353,821-47,260,154-31,824,173-30,643,056-31,821,630-32,215,493-33,827,869-32,718,477-38,093,4507,977,35710,601,47311,841,11310,801,3569,442,18610,497,38311,923,675586,70115,565,78315,926,81716,832,47714,790,74612,545,52812,189,63112,618,84413,201,25514,559,889685,11113,054,99114,580,780
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,902,582
128,874,901
128,874,901
128,874,901
128,874,901
128,874,901
154,245,936
155,897,186
155,897,186
158,441,053
158,441,053
158,441,053
158,441,053
158,441,053
0
0
0
0
0
0
000000158,441,053158,441,053158,441,053158,441,053158,441,053155,897,186155,897,186154,245,936128,874,901128,874,901128,874,901128,874,901128,874,901128,902,58200000000000000000000000000
   Treasury Stock0000000000-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531000-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-2,621,531-1,359,259-1,359,259
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,256,911
1,165,995
1,371,787
900,983
23,107,613
23,808,012
24,912,846
24,988,292
24,844,393
664,243
24,760,176
25,404,040
25,257,155
24,838,209
29,804,395
29,869,093
28,995,175
29,901,224
44,233,299
44,293,818
39,542,679
40,384,048
-2,782,712
0
0
0
0
0
0
000000-2,782,71240,384,04839,542,67944,293,81844,233,29929,901,22428,995,17529,869,09329,804,39524,838,20925,257,15525,404,04024,760,176664,24324,844,39324,988,29224,912,84623,808,01223,107,613900,9831,371,7871,165,9951,256,91100000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue68,642,987
Cost of Revenue-28,458,839
Gross Profit40,184,14840,184,148
 
Operating Income (+$)
Gross Profit40,184,148
Operating Expense-93,797,609
Operating Income-25,154,622-53,613,461
 
Operating Expense (+$)
Research Development29,216,416
Selling General Administrative19,756,915
Selling And Marketing Expenses0
Operating Expense93,797,60948,973,331
 
Net Interest Income (+$)
Interest Income2,534,996
Interest Expense-6,389,100
Other Finance Cost-30,351,854
Net Interest Income26,497,750
 
Pretax Income (+$)
Operating Income-25,154,622
Net Interest Income26,497,750
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,414,018-25,154,622
EBIT - interestExpense = -6,389,100
5,839,998
12,229,098
Interest Expense6,389,100
Earnings Before Interest and Taxes (EBIT)010,803,118
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax4,414,018
Tax Provision--536,598
Net Income From Continuing Ops4,950,6164,950,616
Net Income5,839,998
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-26,497,750
 

Technical Analysis of MEDIPOST Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of MEDIPOST Co. Ltd. The general trend of MEDIPOST Co. Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine MEDIPOST Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MEDIPOST Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 15,885.

The bearish price targets are: 10,770 > 8,960 > 8,920.

Tweet this
MEDIPOST Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MEDIPOST Co. Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MEDIPOST Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MEDIPOST Co. Ltd. The current macd is 1,384.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MEDIPOST Co. Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for MEDIPOST Co. Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the MEDIPOST Co. Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
MEDIPOST Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMEDIPOST Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MEDIPOST Co. Ltd. The current adx is 53.85.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy MEDIPOST Co. Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
MEDIPOST Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MEDIPOST Co. Ltd. The current sar is 10,356.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MEDIPOST Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MEDIPOST Co. Ltd. The current rsi is 59.55. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
MEDIPOST Co. Ltd Daily Relative Strength Index (RSI) ChartMEDIPOST Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MEDIPOST Co. Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the MEDIPOST Co. Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
MEDIPOST Co. Ltd Daily Stochastic Oscillator ChartMEDIPOST Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MEDIPOST Co. Ltd. The current cci is 58.52.

MEDIPOST Co. Ltd Daily Commodity Channel Index (CCI) ChartMEDIPOST Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MEDIPOST Co. Ltd. The current cmo is 13.83.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
MEDIPOST Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartMEDIPOST Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MEDIPOST Co. Ltd. The current willr is -43.74034003.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that MEDIPOST Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MEDIPOST Co. Ltd Daily Williams %R ChartMEDIPOST Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MEDIPOST Co. Ltd.

MEDIPOST Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MEDIPOST Co. Ltd. The current atr is 1,024.

MEDIPOST Co. Ltd Daily Average True Range (ATR) ChartMEDIPOST Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MEDIPOST Co. Ltd. The current obv is 8,287,593.

MEDIPOST Co. Ltd Daily On-Balance Volume (OBV) ChartMEDIPOST Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MEDIPOST Co. Ltd. The current mfi is 67.18.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
MEDIPOST Co. Ltd Daily Money Flow Index (MFI) ChartMEDIPOST Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MEDIPOST Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

MEDIPOST Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MEDIPOST Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.552
Ma 20Greater thanMa 5010,787.000
Ma 50Greater thanMa 1008,578.800
Ma 100Greater thanMa 2007,282.300
OpenGreater thanClose11,870.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of MEDIPOST Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on MEDIPOST Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about MEDIPOST Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MEDIPOST Co. Ltd

I send you an email if I find something interesting about MEDIPOST Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about MEDIPOST Co. Ltd.

Receive notifications about MEDIPOST Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.